Cell surface engineering for regulation of immune reactions in cell therapy

Advances in Experimental Medicine and Biology

Volumn 865, Issue , 2015, Pages 189-209

  Teramura, Yuji ^a   Asif, Sana ^b   Ekdahl, Kristina N ^b   Nilsson, Bo ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Bioartificial pancreas; Biomaterials; Diabetes; Instant blood mediated inflammatory reaction (IBMIR); Islet transplantation; Microencapsulation; PEG lipid; Poly(ethylene glycol) (PEG); Surface modification

Indexed keywords

ARGATROBAN; COMPLEMENT COMPONENT C3B RECEPTOR; LIPOSOME; UROKINASE; GLUCOSE BLOOD LEVEL; IMMOBILIZED PROTEIN; LIPID BILAYER; MACROGOL DERIVATIVE;

ARTICLE; CELL AGGREGATION; CELL ENCAPSULATION; CELL ENGINEERING; CELL VOLUME; CYTOTOXICITY; FIBRINOLYSIS; GRAFT SURVIVAL; HUMAN; HYDROLYSIS; HYDROPHOBICITY; IMMUNE RESPONSE; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BILAYER; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; GENETICS; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; IMMUNOLOGY; ISOGRAFT; METABOLISM; MOUSE; PANCREAS ISLET; PATHOLOGY; PROCEDURES;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GRAFT REJECTION; GRAFT SURVIVAL; IMMOBILIZED PROTEINS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LIPID BILAYERS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYETHYLENE GLYCOLS; TRANSPLANTATION, ISOGENEIC; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84940388134     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-18603-0_12     Document Type: Article

References (50)

1. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell. 1996;85:291-7.
2. Mathis D, Vence L, Benoist C. Beta-cell death during progression to diabetes. Nature. 2001;414:792-8.
3. Ballinge WF, Lacy PE. Transplantation of intact pancreatic-islets in rats. Surgery. 1972;72:175-86.
4. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 2001;50:710-9.
5. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230-8.
6. Bennet W, Sundberg B, Groth CG, Brendel MD, Brandhorst D, Brandhorst H, et al. Incompatibility between human blood and isolated islets of Langerhans: a finding with implications for clinical intraportal islet transplantation? Diabetes. 1999;48:1907-14.
7. Bennet W, Sundberg B, Lundgren T, Tibell A, Groth CG, Richards A, et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation. 2000;69:711-9.
8. Moberg L, Johansson H, Lukinius A, Berne C, Foss A, Kallen R, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet. 2002;360:2039-45.
9. Ozmen L, Ekdahl KN, Elgue G, Larsson R, Korsgren O, Nilsson B. Inhibition of thrombin abrogates the instant blood-mediated inflammatory reaction triggered by isolated human islets: possible application of the thrombin inhibitor melagatran in clinical islet transplantation. Diabetes. 2002;51:1779-84.
10. Goto M, Johansson H, Maeda A, Elgue G, Korsgren O, Nilsson B. Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets. Transplantation. 2004;77:741-7.
11. Goto M, Tjernberg J, Dufrane D, Elgue G, Brandhorst D, Ekdahl KN, et al. Dissecting the instant blood-mediated inflammatory reaction in islet xenotransplantation. Xenotransplantation. 2008;15:225-34.
12. Kang HJ, Lee H, Ha JM, Lee JI, Shin JS, Kim KY, et al. The role of the alternative complement pathway in early graft loss after intraportal porcine islet xenotransplantation. Transplantation. 2014;97:999-1008.
13. Nilsson B, Ekdahl KN, Korsgren O. Control of instant blood-mediated inflammatory reaction to improve islets of Langerhans engraftment. Curr Opin Organ Transplant. 2011;16:620-6.
14. Naziruddin B, Iwahashi S, Kanak MA, Takita M, Itoh T, Levy MF. Evidence for instant bloodmediated inflammatory reaction in clinical autologous islet transplantation. Am J Transplant. 2014;14:428-37.
15. Chen H, Teramura Y, Iwata H. Co-immobilization of urokinase and thrombomodulin on islet surfaces by poly(ethylene glycol)-conjugated phospholipid. J Control Release. 2011;150: 229-34.
16. Chen H, Teramura Y, Iwata H. Immobilization of anticoagulant-loaded liposomes on cell surfaces by DNA hybridization. Biomaterials. 2011;32:7971-7.
17. Luan NM, Teramura Y, Iwata H. Immobilization of soluble complement receptor 1 on islets. Biomaterials. 2011;32:4539-45.
18. Luan NM, Teramura Y, Iwata H. Layer-by-layer co-immobilization of soluble complement receptor 1 and heparin on islets. Biomaterials. 2011;32:6487-92.
19. Takemoto N, Teramura Y, Iwata H. Islet surface modification with urokinase through DNA hybridization. Bioconjug Chem. 2011;22:673-8.
20. Teramura Y, Iwata H. Islets surface modification prevents blood-mediated inflammatory responses. Bioconjug Chem. 2008;19:1389-95.
21. Teramura Y, Iwata H. Improvement of graft survival by surface modification with poly(ethylene glycol)-lipid and urokinase in intraportal islet transplantation. Transplantation. 2011;91:271-8.
22. Teramura Y, Iwata H. Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv Drug Deliv Rev. 2010;62:827-40.
23. Teramura Y, Iwata H. Cell surface modification with polymers for biomedical studies. Soft Matter. 2010;6:1081-91.
24. Cabric S, Sanchez J, Lundgren T, Foss A, Felldin M, Kallen R, et al. Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation. Diabetes. 2007;56:2008-15.
25. Contreras JL, Eckstein C, Smyth CA, Bilbao G, Vilatoba M, Ringland SE, et al. Activated protein C preserves functional islet mass after intraportal transplantation: a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death. Diabetes. 2004;53:2804-14.
26. Hashemi-Najafabadi S, Vasheghani-Farahani E, Shojaosadati SA, Rasaee MJ, Armstrong JK, Moin M, et al. A method to optimize PEG-coating of red blood cells. Bioconjug Chem. 2006;17:1288-93.
27. Lee DY, Lee S, Nam JH, Byun Y. Minimization of immunosuppressive therapy after islet transplantation: combined action of heme oxygenase-1 and PEGylation to islet. Am J Transplant. 2006;6:1820-8.
28. Nacharaju P, Boctor FN, Manjula BN, Acharya SA. Surface decoration of red blood cells with maleimidophenyl-polyethylene glycol facilitated by thiolation with iminothiolane: an approach to mask A, B, and D antigens to generate universal red blood cells. Transfusion. 2005;45:374-83.
29. Scott MD, Murad KL, Koumpouras F, Talbot M, Eaton JW. Chemical camouflage of antigenic determinants: stealth erythrocytes. Proc Natl Acad Sci U S A. 1997;94:7566-71.
30. Stabler CL, Sun XL, Cui W, Wilson JT, Haller CA, Chaikof EL. Surface re-engineering of pancreatic islets with recombinant azido-thrombomodulin. Bioconjug Chem. 2007;18: 1713-5.
31. Elbert DL, Herbert CB, Hubbell JA. Thin polymer layers formed by polyelectrolyte multilayer techniques on biological surfaces. Langmuir. 1999;15:5355-62.
32. Germain M, Balaguer P, Nicolas JC, Lopez F, Esteve JP, Sukhorukov GB, et al. Protection of mammalian cell used in biosensors by coating with a polyelectrolyte shell. Biosens Bioelectron. 2006;21:1566-73.
33. Krol S, del Guerra S, Grupillo M, Diaspro A, Gliozzi A, Marchetti P. Multilayer nanoencapsulation. New approach for immune protection of human pancreatic islets. Nano Lett. 2006;6:1933-9.
34. Veerabadran NG, Goli PL, Stewart-Clark SS, Lvov YM, Mills DK. Nanoencapsulation of stem cells within polyelectrolyte multilayer shells. Macromol Biosci. 2007;7:877-82.
35. Inui O, Teramura Y, Iwata H. Retention dynamics of amphiphilic polymers PEG-lipids and PVA-alkyl on the cell surface. ACS Appl Mater Interfaces. 2010;2:1514-20.
36. Krych-Goldberg M, Atkinson JP. Structure-function relationships of complement receptor type 1. Immunol Rev. 2001;180:112-22.
37. Weisman HF, Bartow T, Leppo MK, Marsh Jr HC, Carson GR, Concino MF, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing postischemic myocardial inflammation and necrosis. Science. 1990;249:146-51.
38. Auchincloss Jr H, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol. 1998; 16:433-70.
39. Hessing M, Vlooswijk RA, Hackeng TM, Kanters D, Bouma BN. The localization of heparinbinding fragments on human C4b-binding protein. J Immunol. 1990;144:204-8.
40. Schmidt CQ, Herbert AP, Hocking HG, Uhrin D, Barlow PN. Translational mini-review series on complement factor H: structural and functional correlations for factor H. Clin Exp Immunol. 2008;151:14-24.
41. Wu YQ, Qu H, Sfyroera G, Tzekou A, Kay BK, Nilsson B, et al. Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine. J Immunol. 2011;186:4269-77.
42. Nilsson PH, Ekdahl KN, Magnusson PU, Qu HC, Iwata H, Ricklin D, et al. Autoregulation of thromboinflammation on biomaterial surfaces by a multicomponent therapeutic coating. Biomaterials. 2013;34:985-94.
43. Teramura Y, Iwata H. Surface modification of islets with PEG-lipid for improvement of graft survival in intraportal transplantation. Transplantation. 2009;88:624-30.
44. Teramura Y, Kaneda Y, Iwata H. Islet-encapsulation in ultra-thin layer-by-layer membranes of poly(vinyl alcohol) anchored to poly(ethylene glycol)-lipids in the cell membrane. Biomaterials. 2007;28:4818-25.
45. Kozlovskaya V, Zavgorodnya O, Chen Y, Ellis K, Tse HM, Cui W, et al. Ultrathin polymeric coatings based on hydrogen-bonded polyphenol for protection of pancreatic islet cells. Adv Funct Mater. 2012;22:3389-98.
46. Zhi ZL, Kerby A, King AJ, Jones PM, Pickup JC. Nano-scale encapsulation enhances allograft survival and function of islets transplanted in a mouse model of diabetes. Diabetologia. 2012;55:1081-90.
47. Teramura Y, Oommen OP, Olerud J, Hilborn J, Nilsson B. Microencapsulation of cells, including islets, within stable ultra-thin membranes of maleimide-conjugated PEG-lipid with multifunctional crosslinkers. Biomaterials. 2013;34:2683-93.
48. Teramura Y, Minh LN, Kawamoto T, Iwata H. Microencapsulation of islets with living cells using polyDNA-PEG-lipid conjugate. Bioconjug Chem. 2010;21:792-6.
49. Teramura Y, Chen H, Kawamoto T, Iwata H. Control of cell attachment through polyDNA hybridization. Biomaterials. 2010;31:2229-35.
50. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-72.